ConductScience.org, home

Paper1981663

The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents.

Peters W and 4 others. Ann Trop Med Parasitol, 1990. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents. Papers, record 1981663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1981663

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents.
PubMed
Journal
Ann Trop Med Parasitol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
1.92
iCite
Revised in PubMed
2019-05-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peters WW
2Ekong RR
3Robinson BLB L
4Warhurst DCD C
5Pan XQX Q

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChloroquineMajor topic
Histamine AntagonistsMajor topic
Plasmodium bergheiMajor topic
Plasmodium yoeliiMajor topic
Animals
Cyproheptadine
Dose-Response Relationship, Drug
Drug Resistance
Histamine H1 Antagonists
Humans
In Vitro Techniques
Ketotifen
Loratadine
Pizotyline
Rats

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
32731386Repurposing Drugs to Fight Hepatic Malaria Parasites.Molecules2020https://conductscience.org/library/papers/32731386PubMed
29061761Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29061761PubMed
28279945Quantitative characterization of hemozoin in Plasmodium berghei and vivax.Int J Parasitol Drugs Drug Resist2017https://conductscience.org/library/papers/28279945PubMed
27048943Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.Bioorg Med Chem Lett2016https://conductscience.org/library/papers/27048943PubMed
25616344Arteether resistance reversal by ketoconazole/fluconazole in rodent malaria parasite Plasmodium vinckei.Parasitol Res2015https://conductscience.org/library/papers/25616344PubMed
23547773Effective treatment with a tetrandrine/chloroquine combination for chloroquine-resistant falciparum malaria in Aotus monkeys.Malar J2013https://conductscience.org/library/papers/23547773PubMed
20807203Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross.Mol Microbiol2010https://conductscience.org/library/papers/20807203PubMed
17846138Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17846138PubMed
16377670In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16377670PubMed
15215144Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15215144PubMed
12069956In vitro increase in chloroquine accumulation induced by dihydroethano- and ethenoanthracene derivatives in Plasmodium falciparum-parasitized erythrocytes.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12069956PubMed
10991848Potent enhancement of the sensitivity of Plasmodium falciparum to chloroquine by the bisbenzylisoquinoline alkaloid cepharanthin.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10991848PubMed
10991845Role of the neurotransmitter reuptake-blocking activity of antidepressants in reversing chloroquine resistance in vitro in Plasmodium falciparum.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10991845PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1981663

GET https://conductscience.org/api/papers/v1/1981663/authors